This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key building block in the production of drugs targeting neurological disorders, such as Alzheimer's disease and other cognitive impairments. Additionally, it is employed in the preparation of peptide-based therapeutics, where its structure aids in enhancing stability and bioavailability. The tert-butoxycarbonyl (Boc) protecting group in the molecule is crucial for selective reactions during multi-step synthetic processes, ensuring precise modifications in the final drug compounds. Its application extends to research and development in medicinal chemistry, where it contributes to the exploration of novel drug candidates with potential therapeutic benefits.